LFFM Fundraising Event Again Reaches a Record Setting Year

By Pamela Goldsmith, MRA Director of Communications | 6 June 2017 In Allies & Partnerships, Events

Nearly 1,000 professionals from the leveraged finance community gathered for the sixth annual Leveraged Finance Fights Melanoma (LFFM) benefit and cocktail party raising a record $1.8 million in funds for the Melanoma Research Alliance (MRA), the largest private funder of melanoma research.

Read More


What Gut Bacteria Tell Us About Treating Melanoma and Other Cancers

By Pamela Goldsmith, MRA Director of Communications | 3 April 2017 In News, Science, Treatment

Despite success in the use of immunotherapy to treat cancer by harnessing the body’s immune system to fight it, a major difficulty continues to be the range of responses to treatment among patients. It’s why researchers are exploring why some cancer patients exhibit astounding results with little side effects while others receive no benefits to the treatment and/or experience severe side effects.

Read More


MRA and BJ’s Wholesale Club Partner to Launch May Campaign

By Pamela Goldsmith, MRA Director of Communications | 3 April 2017 In Allies & Partnerships, Prevention

In today’s dynamic research environment, working as a team is more valuable than ever. This May, in an effort to spotlight Melanoma Awareness month, BJ’s Wholesale Club, a warehouse club operating in 15 states and headquartered in Massachusetts, will launch its first awareness campaign in partnership with MRA to highlight the importance of prevention.

Read More


Trena's Story: An African-American Retiree's Journey with Melanoma

8 June 2016 In Melanoma Stories

“Trena, you have melanoma and you are going to lose your toe. “ WHAT?!?! I am a Black woman in her sixties—that is crazy!!

Read More


The Power of Combination Therapies: One Patient’s Road to Remission

By Pooja H. Rambhia, MD Candidate, Case Western Reserve University | 28 February 2017 In Science, Treatment

Metastatic melanoma can be a devastating diagnosis to receive. Just hearing the word cancer for most is terrifying. While the fear is understandable, today new targeted therapies and immunotherapies are delivering new hope for many.

Read More


Understanding Neoantigens: A Critical Target for Improving Immunotherapy

By Kristen Mueller, Ph.D., MRA Scientific Program Director | 20 January 2017

The approval of eleven new therapies for melanoma since 2011 has led to dramatic changes in how doctors treat melanoma and even more importantly, has led to better outcomes for many patients. Chief among the new therapies are those that target the immune system.

Read More


Tara's Story

By Pamela Goldsmith, MRA Director of Communications | 20 January 2017 In Melanoma Stories

To say that Tara Miller inspired mixed emotions is to begin to understand her life. The strong-willed survivor, who lost her battle to melanoma in 2014, reflected the contradictions that define an indomitable will to live.

Read More


Parallels between Disease States

By Michael Kaplan, MRA President & CEO | 30 November 2016 In Science

Six months ago I was offered the opportunity to serve as President & CEO of MRA and in July, I officially began. For the past 24 years, I’ve worked in the HIV field and am struck by the many parallels that exist between my past work and melanoma.

Read More



Login

×